Evidence map›Paper›PMID 30760879›Full record

Trial reportJournal of human genetics2019

Novel mutations of AXIN2 identified in a Chinese Congenital Heart Disease Cohort.

Meng-Jiao Zhu, Xiao-Yun Ma, Pei-Cheng Ding, Han-Fei Tang, Rui Peng, Lei Lu, Pei-Qiang Li, Bin Qiao, Xue-Yan Yang, Yu-Fang Zheng and 3 more

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Deleterious Rare Mutations ofFrontiers in cardiovascular medicine · 2022
    Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Meng-Jiao ZhuDepartment of Orthodontics, School and Hospital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, 200072, China.
Xiao-Yun MaDepartment of Orthodontics, School and Hospital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, 200072, China.
Pei-Cheng DingDepartment of Cardiothoracic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.
Han-Fei TangDepartment of Vascular Surgery, Institute of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Rui PengObstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics & Development at School of Life Sciences of Fudan University, 20043, Shanghai, China.
Lei LuObstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics & Development at School of Life Sciences of Fudan University, 20043, Shanghai, China.
Pei-Qiang LiInstitute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, 730000, China.
Bin QiaoInstitute of Cardiovascular Disease, General Hospital of Jinan Military Region, Jinan, 250022, China.
Xue-Yan YangState Key Laboratory of Genetic Engineering at School of Life Sciences of Fudan University, 20043, Shanghai, China.
Yu-Fang ZhengObstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics & Development at School of Life Sciences of Fudan University, 20043, Shanghai, China.ORCID http://orcid.org/0000-0002-0488-2624
Hong-Yan WangObstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics & Development at School of Life Sciences of Fudan University, 20043, Shanghai, China.
Yun-Qian GaoObstetrics and Gynecology Hospital, State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics & Development at School of Life Sciences of Fudan University, 20043, Shanghai, China. gaoyq@nicemice.cn.
Feng-Shan ChenDepartment of Orthodontics, School and Hospital of Stomatology, Tongji University, Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, 200072, China. orthodboy@126.com.
Fudan University · CNTongji University · CNShanghai Medical College of Fudan University · CNJinan Military General Hospital · CNLanzhou University · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

China Postdoctoral Science Foundation 2018M641918China Postdoctoral Science Foundation BX20180069National Natural Science Foundation of China (National Science Foundation of China) 31601029National Natural Science Foundation of China (National Science Foundation of China) 81601298National Natural Science Foundation of China (National Science Foundation of China) 81670973
6 · The paper itself

Abstract

Congenital heart defects (CHDs), the most common congenital human birth anomalies, involves complex genetic factors. Wnt/β-catenin pathway is critical for cardiogenesis and proved to be associated with numerous congenital heart abnormities. AXIN2 has a unique role in Wnt/β-catenin pathway, as it is not only an important inhibitor but also a direct target of Wnt/β-catenin pathway. However, whether AXIN2 is associated with human CHDs has not been reported. In our present study, we found a differential expression of Axin2 mRNA during the development of mouse heart, indicating its importance in mouse cardiac development. Then using targeted next-generation sequencing, we found two novel case-specific rare mutations [c.28 C > T (p.L10F), c.395 A > G (p.K132R)] in the sequencing region of AXIN2. In vitro functional analysis suggested that L10F might be a loss-of-function mutation and K132R is a gain-of-function mutation. Both mutations disrupted Wnt/β-catenin pathway and failed to rescue CHD phenotype caused by Axin2 knockdown in zebrafish model. Collectively, our study indicates that rare mutations in AXIN2 might contribute to the risk of human CHDs and a balanced canonical Wnt pathway is critical for cardiac development process. To our knowledge, it is the first study of AXIN2 mutations associated with human CHDs, providing new insights into CHD etiology.

Indexed as

Mutation, MissenseAmino Acid SubstitutionAnimalsAsian PeopleAxin ProteinChildChild, PreschoolChinaCohort StudiesFemaleGene Knockdown TechniquesHeart Defects, CongenitalHigh-Throughput Nucleotide SequencingHumansInfantMaleAXIN2 protein, humanAxin2 protein, mouseaxin2 protein, zebrafishAxin Protein

Identifiers

PMID30760879
OpenAlexW2914704739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.